ARCHIVES

NCI Starts “Exceptional Responders” Study

This article is from The Cancer Letter archive.

Vol. 40 No. 36 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Advisors’ Report On Intramural Program To Recommend Restructuring

April 14, 1995

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

August 26, 2005

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

New Research Training Act May Permit NCI To Help fill Clinical Gaps In Radiotherapy, Medical Oncology

July 26, 1974

Abbott PCR Test For HCV Load Sensitive to Within 12 IU/mL

May 27, 2011

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

October 19, 2007